Disease Studies

AI Enabled Precision Medicine: Patient Stratification, Drug Repurposing and Combination Therapies

Access to huge patient populations with well-characterized datasets, coupled with novel analytical methods, enables the stratification of complex diseases into multiple distinct forms. Patients can be accurately placed into distinguishable subgroups that have different disease causes and influences. This offers huge promise for innovation in drug discovery, drug repurposing, and the delivery of more accurately personalized care to patients. Complex diseases such as cancer, dementia, and diabetes are caused by multiple genetic, epidemiological, and/or environmental factors.

Understanding the detailed architecture of these diseases requires a new generation of analytical tools that can identify combinations of genomic and nongenomic features (disease signatures) that accurately distinguish the disease subgroups. These sub-groups can be studied to find novel targets for drug discovery or repurposing, especially in the areas of unmet medical need and for selecting the best treatments available for an individual patient based on their personal genetic makeup, phenotype, and co-morbidities/co-prescriptions. This chapter describes new developments in combinatorial, multi-factorial analysis methods, and their application in patient stratification for complex diseases. Case studies are described in novel target discovery for a non-T2 asthma patient sub-group with distinct unmet medical need and in drug repurposing in a triple negative breast cancer population.

To view the publication in full, please see https://library.oapen.org/bitstream/handle/20.500.12657/43405/external_content.pdf?sequence=1#page=131.

More News & Media

View All News & Media

Combinatorial analytics: An essential tool for the delivery of precision medicine and precision agriculture

An Opinion, published in the new Open Access Journal Artificial Intelligence in the Life Sciences from Elsevier, describes the…

Read more

Combinatorial analysis of phenotypic and clinical risk factors associated with hospitalized COVID-19 patients

A study using de-identified clinical claims and labs data for US COVID-19 patients. We replicated previous findings around the…

Read more

The COVID-19 PHARMACOME: Rational Selection of Drug Repurposing Candidates from Multimodal Knowledge Harmonization

The SARS-CoV-2 pandemic has challenged researchers at a global scale. The scientific community’s massive response has resulted in a…

Read more

Keep in touch

Please enter your email address if you would like to be kept informed of our work here at PrecisionLife. Note that our Privacy Policy and Terms & Conditions apply.

  • This field is for validation purposes and should be left unchanged.

Contact us

If you have any questions or would like to speak to us in terms of potential collaborations or partnership opportunities, please get in touch using the form below or email info@precisionlife.com and we will get back to you as soon as we can. Note that our Privacy Policy and Terms & Conditions apply.


Unit 8b Bankside
Hanborough Business Park
Long Hanborough, OX29 8LJ


1 Broadway Fl 14
MA 02142-1187


Agern Allé 3


Chmielna 73m
00-801 Warszawa

  • This field is for validation purposes and should be left unchanged.